Glaxo reports Lucozade sales pressure

Drug maker GlaxoSmithKline today said sales of its Lucozade drink slumped 12% as it announced lower quarterly profits amid slumping US performance.

Glaxo reports Lucozade sales pressure

Drug maker GlaxoSmithKline today said sales of its Lucozade drink slumped 12% as it announced lower quarterly profits amid slumping US performance.

The pharmaceuticals giant said its sports and energy drinks suffered as UK consumers shied away from impulse buys.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited